SETH SANDESH (CEO) received a stock award from ACTINIUM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/4/2026ACC: 0001213900-26-097741
DirectorOfficer· CEO
Since Jul 2018
+2.91M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
2.91M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+753.60K
Price / share
—
Trade value
—
% of position
408.5%
9/2/2026
184.48K→938.08K
Common Stock
Direct
Shares
+1.03M
Price / share
—
Trade value
—
% of position
109.5%
9/2/2026
938.08K→1.97M
Total
Net shares
+1.78M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | A · Award | +753.60K | — | — | 408.5% | 184.48K | 938.08K |
| Common Stock Direct | 9/2/2026 | A · Award | +1.03M | — | — | 109.5% | 938.08K | 1.97M |
| Total | +1.78M | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.13M shares
Shares
+1.13M
Strike price
1.00
Held after
1.13M
Exercisable
—
9/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.13M shares | 9/2/2026 | A · Award | +1.13M | 1.00 | — | 1.13M |